Evidence map›Paper›PMID 27588218›Full record

ArticleVirology & mycology : infectious diseases2014

Human Respiratory Coronaviruses Detected In Patients with Influenza-Like Illness in Arkansas, USA.

Camila S Silva, Lisa B Mullis, Olavo Pereira, Linda J Saif, Anastasia Vlasova, Xuming Zhang, Randall J Owens, Dale Paulson, Deborah Taylor, Lia M Haynes and 1 more

Open access · greenAbstract read
In one paragraph

Article in Virology & mycology : infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molnupiravir Inhibits Replication of MultiplePathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Camila S SilvaDivision of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, USA.
Lisa B MullisDivision of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, USA.
Olavo PereiraDivision of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, USA.
Linda J SaifFood Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, USA.
Anastasia VlasovaFood Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, USA.
Xuming ZhangDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, USA.
Randall J OwensPublic Health Laboratory, Arkansas Department of Health, Little Rock, USA.
Dale PaulsonPublic Health Laboratory, Arkansas Department of Health, Little Rock, USA.
Deborah TaylorCenter for Biologics Evaluation and Research, US FDA, Rockville, USA.
Lia M HaynesNational Center for Immunization and Respiratory Diseases, Division of Viral Diseases, Gastroenteritis and Respiratory Viruses Laboratory Branch, Centers for Disease Control and Prevention (CDC), USA.
Marli P AzevedoDivision of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, USA.
National Center for Toxicological Research · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Acute respiratory viruses often result in significant morbidity and mortality. The potential impact of human respiratory coronavirus (CoV) infections was underestimated until the severe acute respiratory syndrome (SARS-CoV) outbreak in 2003, which showed that new, highly pathogenic coronaviruses could be introduced to humans, highlighting the importance of monitoring the circulating coronaviruses. The use of sensitive molecular methods has contributed to the differential diagnosis of viruses circulating in humans. Our study aim was to investigate the molecular epidemiology of human CoV strains circulating in Arkansas, their genetic variability and their association with reported influenza-like symptoms. We analyzed 200 nasal swab samples, collected by the Arkansas Department of Health in 2010, for influenza diagnosis. All samples were from patients showing acute respiratory symptoms while testing negative for influenza. Samples were pre-screened, using a quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) multiprobe for coronavirus, and subjected to confirmatory pancoronavirus and/or strain-specific reverse transcriptase (RT)-PCR followed by sequence analysis. Seventy-nine samples (39.5%) were positive by qRT-PCR and 35 samples (17.5%) were confirmed by conventional RT-PCR. Twenty-three of the confirmed samples (59%) were sequenced. The most frequent strain detected was HCoV-OC43-like followed by NL63-like; only one sample was positive for HCoV-229E and one for HCoV-HKU1. Feline-like CoV strains were detected in three samples, representing possible evidence of interspecies transmission or a new human strain. Seventeen percent of the coronavirus positive samples were also positive for other respiratory viruses, such as Respiratory Syncytial Virus (RSV), Parainfluenza 2 and 3, and Rhinovirus. Thus, HCoV-OC43, NL63, HKU1 and new feline-like strains were circulating in Arkansas in 2010. HCoV was the sole respiratory virus detected in 16% of the patients who showed acute respiratory symptoms with negative diagnoses for influenza virus.

Indexed as

Human respiratory coronavirusesInfluenzaMolecular epidemiology

Identifiers

PMID27588218
PMCPMC5004774
OpenAlexW2520283051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.